Target intelligence / Profile preview

Pancreatic progenitor cell differentiation and proliferation factor homolog pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The Pancreatic progenitor cell differentiation and proliferation factor homolog pseudogene (ENSG00000248105) is a non-protein-coding genomic region classified as a pseudogene, meaning it is a remnant of a gene that has lost the capacity to code for a functional protein. Pseudogenes can result from gene duplication or retrotransposition but generally lack gene expression or function. This particular pseudogene does not act as a receptor, enzyme, transporter, or any other classical molecular target, and there is no evidence supporting a therapeutic or biological function. Because of these characteristics, it is not considered a valid therapeutic target or biomarker. Key clarification: - The presence of the term "pseudogene" means this entry is not a functional gene or target. - It is not considered a receptor, enzyme, transporter, or any type of drug target, nor does it have clear biological or disease functions based on current knowledge. - The systematic Ensembl name and ID are the most accurate descriptors[2]. If you are interested in the genuine protein-coding factors involved in pancreatic progenitor cell differentiation (such as PDX1, NKX6-1, etc.), those are actual targets with significant roles in pancreas development and diabetes therapy[1][3][5][7]. This pseudogene is unrelated to those functions.

Beyond the preview

Go deeper on Pancreatic progenitor cell differentiation and proliferation factor homolog pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic progenitor cell differentiation and proliferation factor homolog pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call